申请人:Neuropore Therapies, Inc.
公开号:US20200308163A1
公开(公告)日:2020-10-01
The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.